Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Q: What does CUSIP 92840H400 represent in this 13F holders report?

CUSIP 92840H400 is the security identifier for VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q3 2023?

34 institutional investors reported VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 92840H400

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 3,003,814
Total 13F value: $15,739,243
Share change: +1,808,008
Put/Call ratio: 27%
SEC-reported price per share: $5.24
Number of holders: 34
Value change: +$10,117,983
Number of buys: 23
Number of sells: 17
Shares outstanding: 42,874,646

Security key

92840H400

Report period

Q3 2023

Institutions

Top holders

VTGN full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Vistagen Therapeutics, Inc. SEC filings Vistagen Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92840H400

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Venrock Healthcare Capita...

Disclosed value leader

Venrock Healthcare Capita...

Comparable rows

0/15

Latest evidence

30 Jun 2023

3/4/5 13F Highest disclosed value: $35,434,220 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Venrock Healthcare Capital Partners II, L.P. has the largest disclosed position value at $35.43M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Venrock Healthcare Capital Partners II, L.P.'s linked filing trail.

Disclosed position value Top 5

Venrock Healthcare Capital Partne... $35.43M

VANGUARD GROUP INC $418.7K

GSA CAPITAL PARTNERS LLP $372K

BlackRock Finance, Inc. $196.4K

MILLENNIUM MANAGEMENT LLC $189K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Venrock Healthcare Capital Partners II, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$35,434,220 20,637,286 shares	—	12 Jul 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$418,715 223,911 shares	—	30 Jun 2023
GSA CAPITAL PARTNERS LLP	13F Company 13F	— denominator unverified	$372,000 198,816 shares	—	30 Jun 2023
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$196,361 105,006 shares	—	30 Jun 2023
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$189,001 101,070 shares	—	30 Jun 2023
H. Ralph Snodgrass	3/4/5 PRES./CHIEF SCIENTIFIC OFFICER 3/4/5	— denominator unverified	$169,741 98,859 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,003,814

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend